Tolcapone-Enhanced Neurocognition in Healthy Adults: Neural Basis and Predictors

BACKGROUND: Failure of procognitive drug trials in schizophrenia may reflect the clinical heterogeneity of schizophrenia, underscoring the need to identify biomarkers of treatment sensitivity. We used an experimental medicine design to test the procognitive effects of a putative procognitive agent,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhakta, Savita G, Light, Gregory A, Talledo, Jo A, Balvaneda, Bryan, Hughes, Erica, Alvarez, Alexis, Rana, Brinda K, Young, Jared W, Swerdlow, Neal R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Regular Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716101/
https://www.ncbi.nlm.nih.gov/pubmed/29020372
http://dx.doi.org/10.1093/ijnp/pyx074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716101/
https://www.ncbi.nlm.nih.gov/pubmed/29020372
http://dx.doi.org/10.1093/ijnp/pyx074

Ejemplares similares